Delcath Systems, Inc. (NASDAQ: DCTH) reported top-line results from the metastatic colorectal (adenocarcinoma) cohort of the Phase II clinical trial of the Delcath chemosaturation system with melphalan in the treatment of patients with unresectable liver cancerThe Company also confirmed plans to i

read more>>

Personalized approach to cancer medicine allows doctors to identify lung cancer patients who benefit from early treatment with TarcevaRoche (SIX: RO, ROG; OTCQX: RHHBY) announced  that the European Commission has approved Tarceva® (erlotinib) for use in patients with a genetically distinct type

read more>>

Patients who arrive in the emergency room complaining of abdominal pain often have to undergo a type of endoscopy—an invasive and sometimes dangerous test— so doctors can determine if the problem is in the pancreasTaking an MRI scan is a safer alternative, but the resulting images often aren

read more>>

Alexion Pharmaceuticals (ALXN) may well have just hit the tip of the iceberg with the number of diseases its drug Soliris can treatSoliris, Alexion's only drug, is approved in over 35 countries to treat one rare life-threatening blood disorder called paroxysmal nocturnal hemoglobinuria, or PNHBut

read more>>

Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company,  announced positive data from several studies designed to evaluate the safety of switching to REPLAGAL (agalsidase alfa) from Fabrazyme® (agalsidase beta) and the long-term safety and benefits of switching to VPR

read more>>

Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) announced that the independent Data Safety Monitoring Board (DSMB) for the Company's pivotal Phase 3 X-PECT study of KRX-0401 (perifosine) in patients with refractory advanced colorectal cancer has completed a pre-specified interim analysis for safety

read more>>

Texas Children’s Hospital in Houston announced that it is the first pediatric hospital in the United States to implant an artificial heart into the chest of a 17-year-old patient as the only option to save his lifeThe history-making patient underwent a rare 15-hour operation on May 22 and is cur

read more>>

Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, announced the publication of clinical data on its lead product JX-594 in the journal NatureFor the first time in humans,

read more>>

An experimental treatment for Lou Gehrig’s disease won fast track and orphan drug designations from the Food and Drug Administration, potentially speeding the drug’s development by Neuraltus Pharmaceuticals IncNP-001, the Palo Alto company’s treatment for amyotrophic lateral sclerosis, or AL

read more>>

Minimally invasive surgery to treat scoliosis in teenagers is now a "feasible option," according to Vishal Sarwahi, M.D., Director of Spine Deformity Surgery at Montefiore Medical Center"This new procedure to correct curvature of the spine involves three small incisions in the back, as opposed to

read more>>